date:Jul 06, 2012
ood.
Removed from market
In a document to manufacturers the FDA said: FDAs assessment of the available data on these types of compounds has indicated the need to consider factors in addition to those traditionally considered by the Agency at similar exposure levels.
These include additional possible toxic endpoints (e.g., effects on pre- and post-natal development and reproductive health and function), perfluorinated carbon chain lengths, and appropriate animal models.
consumer exposure to t